Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 54.91 CNY -0.36% Market Closed
Updated: May 25, 2024

Hangzhou Tigermed Consulting Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hangzhou Tigermed Consulting Co Ltd
Cost of Revenue Peer Comparison

Comparables:
603259
300759
2269
1548
M
688114

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Cost of Revenue
-¥4.5B
CAGR 3-Years
-35%
CAGR 5-Years
-26%
CAGR 10-Years
-36%
WuXi AppTec Co Ltd
SSE:603259
Cost of Revenue
-¥23.6B
CAGR 3-Years
-28%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Cost of Revenue
-¥7.6B
CAGR 3-Years
-28%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Cost of Revenue
-¥10.2B
CAGR 3-Years
-49%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Genscript Biotech Corp
HKEX:1548
Cost of Revenue
-$430m
CAGR 3-Years
-47%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
M
MGI Tech Co Ltd
SSE:688114
Cost of Revenue
-¥2B
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hangzhou Tigermed Consulting Co Ltd's Cost of Revenue?
Cost of Revenue
-4.5B CNY

Based on the financial report for Mar 31, 2024, Hangzhou Tigermed Consulting Co Ltd's Cost of Revenue amounts to -4.5B CNY.

What is Hangzhou Tigermed Consulting Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-36%

Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Hangzhou Tigermed Consulting Co Ltd have been -35% over the past three years , -26% over the past five years , and -36% over the past ten years .